Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1471
https://www.valueinhealthjournal.com/article/S1098-3015(16)32837-6/fulltext
Title : Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32837-6&doi=10.1016/j.jval.2016.09.1471
First page : A602
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1384
Categories :
Tags :
Regions :
ViH Article Tags :